美股市場個股詳情
JAZZ 爵士製藥
- 124.710
- +5.470+4.59%
交易中 11/21 14:22 (美東)
75.39億總市值17.66市盈率TTM
125.100最高價120.070最低價50.72萬股成交量121.840今開119.240昨收6231.78萬成交額0.87%換手率20.44市盈率(靜)6045.46萬總股本134.17052周最高1.81市淨率73.17億流通值99.06052周最低--股息TTM5866.99萬流通股194.730歷史最高--股息率TTM4.22%振幅0.515歷史最低122.861平均價1股每手
關於爵士製藥公司
Jazz Pharmaceuticals是一家位於愛爾蘭的生物製藥公司，主要專注於睡眠障礙和腫瘤的治療。Jazz在神經科學和腫瘤適應症領域有9種獲批藥物;其產品組合包括治療嗜睡症的Xyrem和Xywav，治療轉移性小細胞肺癌的Zepzelca，治療急性淋巴細胞白血病的Rylaze，以及治療急性髓細胞白血病的Vyxeos。2021年5月，Jazz收購了GW Pharmaceuticals，獲得了其主要產品Epidiolex，用於治療嚴重、罕見類型的癲癇。
公司介紹
公司代碼JAZZ
公司名稱爵士製藥
上市日期2007/06/01
發行價格18.00
成立日期2005
CEOMr. Bruce C. Cozadd
所屬市場納斯達克
員工數量2800
年結日12-31
公司地址Waterloo Exchange,Waterloo Road,5th Floor
城市Dublin
省份都柏林
國家愛爾蘭共和國
郵編4
電話353-1-634-7800
董事高管
- 姓名
- 職務
- 年薪
- Bruce C. Cozadd
- Chairman of the Board and Chief Executive Officer
- 1534.12萬
- Neena M. Patil
- Executive Vice President and Chief Legal Officer
- 387.74萬
- Patricia Carr
- Senior Vice President and Chief Accounting Officer
- 140.10萬
- Philip L. Johnson
- Executive Vice President and Chief Financial Officer
- --
- Renee D. Gala
- President and Chief Operating Officer
- 543.44萬
- Samantha Pearce
- Senior Vice President, Europe and International
- --
- Dr. Robert Iannone, M.D.
- Executive Vice President and Global Head of Research and Development
- 497.91萬
- Liz Henderson
- Senior Vice President, Technical Operations
- --
- Heather Ann McSharry
- Independent Director
- 54.38萬
- Dr. Mark D. Smith, M.D.
- Independent Director
- 52.13萬
- Rick E. Winningham
- Lead Independent Director
- 57.13萬
- Anne O'Riordan
- Independent Director
- 52.38萬
- Patrick G. Enright
- Independent Director
- 52.63萬
- Jennifer E. Cook
- Independent Director
- 53.38萬
- Patrick Thomas Kennedy
- Independent Director
- --
- Dr. Norbert G. Riedel,PhD
- Independent Director
- 53.38萬
- Kenneth W. O'Keefe
- Independent Director
- 51.38萬
- Laura J. Hamill
- Independent Director
- --
- Seamus C. Mulligan
- Independent Director
- 53.13萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據